Epigallocatechin gallate and theaflavins independently alleviate cyclophosphamide-induced ovarian damage by inhibiting the overactivation of primordial follicles and follicular atresia
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 92, 153752
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81671394, 81873824, 82001498)
This publication has 49 references indexed in Scilit:
- Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancerCancer, 2011
- Detection of DNA damage in oocytes of small ovarian follicles following phosphoramide mustard exposures of cultured rodent ovaries in vitroToxicology and Applied Pharmacology, 2011
- Oxidative Damage Increases and Antioxidant Gene Expression Decreases with Aging in the Mouse OvaryBiology of Reproduction, 2010
- Use of Hormonal Protection for Chemotherapy-induced GonadotoxicityClinical Obstetrics and Gynecology, 2010
- Fertility preservation and infertility treatment in breast cancer patientsWiener Medizinische Wochenschrift, 2010
- Primary ovarian insufficiencyThe Lancet, 2010
- Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cellsCellular & Molecular Immunology, 2010
- Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial folliclesHuman Molecular Genetics, 2009
- Cancer prevention by tea: animal studies, molecular mechanisms and human relevanceNature Reviews Cancer, 2009
- Regulating the Age-Related Oxidative Damage, Mitochondrial Integrity, and Antioxidative Enzyme Activity in Fischer 344 Rats by Supplementation of the Antioxidant Epigallocatechin-3-GallateRejuvenation Research, 2008